Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Wehner

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
European Journal of Pediatrics|February 7, 1998
Outcome in tall stature. Final height and psychological aspects in 220 patients with and without treatmentG Binder, M L Grauer, A V Wehner, et al.
Journal of Medicinal Chemistry|April 21, 2001
Discovery of an orally active non-peptide fibrinogen receptor antagonist based on the hydantoin scaffoldH U Stilz, W Guba, B Jablonka, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 13, 2004
alpha4beta1-integrin blockade and cyclosporine decreases the prevalence and severity of transplant vasculopathy in a rat transplant modelM H C Richter, V Wehner, M Kock, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2000
RGD mimetics containing a central hydantoin scaffold: alpkha(v)beta3 vs alpha(IIb)beta3 selectivity requirementsA Peyman, V Wehner, J Knolle, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2001
alpha(v)beta(3) Antagonists based on a central thiophene scaffoldA Peyman, K Scheunemann, D W Will, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
European Journal of Pediatrics|February 7, 1998
Outcome in tall stature. Final height and psychological aspects in 220 patients with and without treatmentG Binder, M L Grauer, A V Wehner, et al.
Journal of Medicinal Chemistry|April 21, 2001
Discovery of an orally active non-peptide fibrinogen receptor antagonist based on the hydantoin scaffoldH U Stilz, W Guba, B Jablonka, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 13, 2004
alpha4beta1-integrin blockade and cyclosporine decreases the prevalence and severity of transplant vasculopathy in a rat transplant modelM H C Richter, V Wehner, M Kock, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2000
RGD mimetics containing a central hydantoin scaffold: alpkha(v)beta3 vs alpha(IIb)beta3 selectivity requirementsA Peyman, V Wehner, J Knolle, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2001
alpha(v)beta(3) Antagonists based on a central thiophene scaffoldA Peyman, K Scheunemann, D W Will, et al.
Pageof 1